Locus Biosciences

Venture-backed company
As of · the latest observation of this company; each round carries its own date

4 additional officers and directors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 1 lender
    credit on record

    Borrows from Hercules Capital, Inc.: $3.01M of reported principal, first reported in a BDC schedule for 31 Dec 2022.

    Venture debt changes the cap table's risk and signals the company is extending runway without a new round.

    InferenceBDC portfolio schedules, matched to this company (high match)For Investors, lendersCredit →
  2. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  3. 6 directors
    board

    6 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
unknownsec.gov
Revenue range (Form D)
unknownsec.gov
Rounds on record
0
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

3 rounds
  1. Jan 28, 2022
    Form D equity offering · $10.6M (form d sold) · 3 investors
    Fact Form D · “Locus Biosciences, Inc. filed Form D: $10,569,989 sold of $19,983,396, Biotechnology”
  2. Sep 18, 2017
    Form D equity offering · $7.0M (form d sold) · 2 investors
    Fact Form D · “Locus Biosciences, Inc. filed Form D: $7,000,000 sold of $14,000,000, Biotechnology”
  3. Jan 13, 2016
    Form D equity offering · $1.3M (form d sold) · 62 investors
    Fact Form D · “Locus Biosciences, Inc. filed Form D/A: $1,333,618 sold of $1,500,000, Biotechnology”

Investors on record

2 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 2 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 2 listingseach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

1 position in BDC schedules, matched to this company
  • Hercules Capital, Inc. term loan, senior secured · $3.0M principal
    first reported in a BDC schedule for Dec 31, 2022matures Jul 1, 2025match high, 95%Facility

People

4 officers, 6 directors
Show all 6 officers and directors

Timeline

4 events
  1. Feb 14, 2022
    Locus Biosciences, Inc. filed Form D: $10,569,989 sold of $19,983,396, Biotechnology
    Form D filed Fact Form D
  2. Oct 2, 2017
    Locus Biosciences, Inc. filed Form D: $7,000,000 sold of $14,000,000, Biotechnology
    Form D filed Fact Form D
  3. Apr 15, 2016
    Locus Biosciences, Inc. filed Form D/A: $1,333,618 sold of $1,500,000, Biotechnology
    Form D filed Fact Form D
  4. Jan 27, 2016
    Locus Biosciences, Inc. filed Form D: $150,388 sold of $1,000,000, Biotechnology
    Form D filed Fact Form D

Evidence

66 observations
Every observation on this company
  • Entity type: Corporation Feb 14, 2022 Fact Form D
  • Entity type: Corporation Oct 2, 2017 Fact Form D
  • Entity type: Corporation Apr 15, 2016 Fact Form D
  • Entity type: Corporation Jan 27, 2016 Fact Form D
  • Form D industry group: Biotechnology Feb 14, 2022 Fact Form D
  • Form D industry group: Biotechnology Oct 2, 2017 Fact Form D
  • Form D industry group: Biotechnology Apr 15, 2016 Fact Form D
  • Form D industry group: Biotechnology Jan 27, 2016 Fact Form D
  • Amendment: false Feb 14, 2022 Fact Form D
  • Amendment: false Oct 2, 2017 Fact Form D
  • Amendment: true Apr 15, 2016 Fact Form D
  • Amendment: false Jan 27, 2016 Fact Form D
  • Revenue range (Form D): Decline to Disclose Feb 14, 2022 Fact Form D
  • Revenue range (Form D): Decline to Disclose Oct 2, 2017 Fact Form D
  • Revenue range (Form D): Decline to Disclose Apr 15, 2016 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jan 27, 2016 Fact Form D
  • Incorporated: withinFiveYears Feb 14, 2022 Fact Form D
  • Incorporated: withinFiveYears Oct 2, 2017 Fact Form D
  • Incorporated: withinFiveYears Apr 15, 2016 Fact Form D
  • Incorporated: withinFiveYears Jan 27, 2016 Fact Form D
  • Jurisdiction: Delaware Feb 14, 2022 Fact Form D
  • Jurisdiction: Delaware Oct 2, 2017 Fact Form D
  • Jurisdiction: NORTH CAROLINA Apr 15, 2016 Fact Form D
  • Jurisdiction: NORTH CAROLINA Jan 27, 2016 Fact Form D
  • Amount sold (Form D): $10.6M Feb 14, 2022 Fact Form D
  • Amount sold (Form D): $7.0M Oct 2, 2017 Fact Form D
  • Amount sold (Form D): $1.3M Apr 15, 2016 Fact Form D
  • Amount sold (Form D): $150,388 Jan 27, 2016 Fact Form D
  • Offering amount (Form D): $20.0M Feb 14, 2022 Fact Form D
  • Offering amount (Form D): $14.0M Oct 2, 2017 Fact Form D
  • Offering amount (Form D): $1.5M Apr 15, 2016 Fact Form D
  • Offering amount (Form D): $1.0M Jan 27, 2016 Fact Form D
  • Exemptions: 06b Feb 14, 2022 Fact Form D
  • Exemptions: 06b Oct 2, 2017 Fact Form D
  • Exemptions: 06b Apr 15, 2016 Fact Form D
  • Exemptions: 06b Jan 27, 2016 Fact Form D
  • First sale: 2022-01-28 Feb 14, 2022 Fact Form D
  • First sale: 2017-09-18 Oct 2, 2017 Fact Form D
  • First sale: 2016-01-13 Apr 15, 2016 Fact Form D
  • First sale: 2016-01-13 Jan 27, 2016 Fact Form D
  • Investors (Form D): 3 Feb 14, 2022 Fact Form D
  • Investors (Form D): 2 Oct 2, 2017 Fact Form D
  • Investors (Form D): 62 Apr 15, 2016 Fact Form D
  • Investors (Form D): 11 Jan 27, 2016 Fact Form D
  • Minimum investment (Form D): 0 Feb 14, 2022 Fact Form D
  • Minimum investment (Form D): 0 Oct 2, 2017 Fact Form D
  • Minimum investment (Form D): 0 Apr 15, 2016 Fact Form D
  • Minimum investment (Form D): 0 Jan 27, 2016 Fact Form D
  • Securities offered: equity Feb 14, 2022 Fact Form D
  • Securities offered: equity Oct 2, 2017 Fact Form D
  • Securities offered: equity Apr 15, 2016 Fact Form D
  • Securities offered: equity Jan 27, 2016 Fact Form D
  • Office address: Feb 14, 2022 Fact Form D
  • Office address: Oct 2, 2017 Fact Form D
  • Office address: Apr 15, 2016 Fact Form D
  • Office address: Jan 27, 2016 Fact Form D
  • Listed on portfolio page: Artis Ventures Management, L.P. Oct 1, 2026 Fact Firm website
  • Listed on portfolio page: Artis Capital Management, L.P. Sep 30, 2026 Fact Firm website
  • Listed on portfolio page: Artis Capital Management, L.P. Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Artis Ventures Management, L.P. Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Artis Capital Management, L.P. Sep 15, 2026 Fact Firm website
  • Listed on portfolio page: Artis Ventures Management, L.P. Sep 15, 2026 Fact Firm website
  • Year of incorporation: 2017 Feb 14, 2022 Fact Form D
  • Year of incorporation: 2015 Oct 2, 2017 Fact Form D
  • Year of incorporation: 2015 Apr 15, 2016 Fact Form D
  • Year of incorporation: 2015 Jan 27, 2016 Fact Form D

Record history

1 identity change, 4 dated events on the change ledger, latest event first
  • Identifier attached
    2026-10-01
  • Form D filed
    2022-02-14source on record
  • Form D filed
    2017-10-02source on record

+2 more changes on this record's ledger

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.